Abstract 518: AB801 is a highly potent and selective AXL kinase inhibitor that demonstrates significant anti-tumor activity
Paprcka, Susan Lee, Goshayeshi, Armon, Liu, Suan, Flores, Ruben, Rocha, Lauren, Leslie, Jhansi L., Miles, Dillon H., Foley, Corinne N., Qu, Shiwei, Lamani, Manjunath, Paladugu, Srinivas, Huang, Hsin-Ting, Tribewal, Nidhi, Chen, Ada, Kulusich, Joseph, Garrido-Shaqfeh, Stefan, Fabila, Patricia, Jafri, Salema, Devarajan, Anuja, Fernandez-Salas, Ester
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Get full text
Journal Article